Cell Biotech Co., Ltd.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Public
- Established
- 1995-01-01
- Employees
- 136
- Market Cap
- -
- Website
- http://www.cellbiotech.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome
Phase 3
Completed
- Conditions
- Irritable Bowel Syndrome
- First Posted Date
- 2010-03-18
- Last Posted Date
- 2011-12-23
- Lead Sponsor
- Cell Biotech Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT01088971
- Locations
- 🇰🇷
Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of
News
No news found